What is the translation of " EMBOLIJSKI " in English?

• embolic

Examples of using Embolijski in Croatian and their translations into English

Embolijski i trombotički događaji.
Embolic and thrombotic events.

Trombotički i embolijski događaji.
Thrombotic and embolic events.

Venski embolijski i trombotički događaji c, d, i.
Venous embolic and thrombotic eventsc, d, i.

Povećanje mase crvenih krvnih stanica može povećati rizik od embolijskih i trombotskih događaja.
An increase in red blood cell mass may increase the risk of embolic and thrombotic events.

Venski embolijski i trombotski događaji vidjeti dio 4.4.
Venous embolic and thrombotic events see section 4.4.

Provenge je potrebno primjenjivati s oprezom u bolesnika s embolijskim i trombotičkim poremećajima u anamnezi.
Provenge should be used with caution in patients with a history of embolic and thrombotic disorders.

Arterijski embolijski i trombotski događaji stupnja 3 prijavljeni su u 1,2% bolesnika.
Grade 3 arterial embolic and thrombotic events were reported in 1.2% of patients.

Aksitinib nije ispitivan u bolesnika koji su u prethodnih 12 mjeseci imali neki arterijski embolijski ili trombotski događaj.
Axitinib has not been studied in patients who had an arterial embolic or thrombotic event within the previous 12 months.

Smrtonosni arterijski embolijski i trombotski događaji prijavljeni su u 0,3% bolesnika koji su primali aksitinib.
Fatal arterial embolic and thrombotic events were reported in 0.3% patients receiving axitinib.

Spinalna anestezija i višekratne intramuskularne injekcije mogu dodatno povećati rizik od(trombo) embolijskih događaja tijekom i odmah nakon primjene Glybere.
Spinal anaesthesia and multiple intramuscular injections may further increase the risk of(thrombo) embolic events at and shortly after administration of Glybera.

Arterijski embolijski i trombotski događaji stupnja 3/4 prijavljeni su u 3,3% bolesnika koji su primali aksitinib.
Grade 3/4 arterial embolic and thrombotic adverse reactions were reported in 3.3% of patients receiving axitinib.

U objedinjenim kliničkim ispitivanjima aksitiniba(N 672) u terapiji bolesnika s RCC-om, arterijski embolijski i trombotski događaji prijavljeni su u 2,8% bolesnika koji su primali aksitinib.
In pooled clinical studies with axitinib(N 672) for the treatment of patients with RCC, arterial embolic and thrombotic events were reported in 2.8% of patients receiving axitinib.

Naziv embolijski moždani udar odnosi se na blokadu arterije uzrokovanu arterijskim embolusom, putujućom česticom ili debrisom, u arterijskoj krvnoj struji, koja potječe s drugog mjesta.
An embolic stroke refers to the blockage of an artery by an embolus, a traveling particle or debris in the arterial bloodstream originating elsewhere.

Tablica 4: Moždani udari i sistemski embolijski događaji u ispitivanju ENGAGE AF-TIMI 48 mITT, tijekom liječenja.
Table 4: Strokes and Systemic Embolic Events in the ENGAGE AF-TIMI 48 Study- mITT, on-treatment.

Embolijski infarkti nastaju kada se embolusi formirani negdje drugdje u tijelu, obično u srcu kao posljedica atrijske fibrilacije ili u karotidnim arterijama, otkinu, uđu u moždanu cirkulaciju, te se smjeste i začepe krvnu žilu.
Embolic infarction occurs when emboli formed elsewhere in the circulatory system, typically in the heart as a consequence of atrial fibrillation, or in the carotid arteries, break off, enter the cerebral circulation, then lodge in and block brain blood vessels.

U kasnijoj fazi fibrocartilaginous embolijski mijelopatija, oteklina može biti prisutan na mjestu blokade.
In the later stage of fibrocartilaginous embolic myelopathy, swelling may be present at the site of the blockage.

U kliničkim ispitivanjima aksitiniba prijavljeni su venski embolijski i trombotski događaji(uključujući plućnu emboliju, duboku vensku trombozu i okluziju/trombozu mrežnične vene) vidjeti dio 4.8.
In clinical studies with axitinib, venous embolic and thrombotic events(including pulmonary embolism, deep vein thrombosis, and retinal vein occlusion/thrombosis) were reported see section 4.8.

U kliničkim ispitivanjima aksitiniba prijavljeni su arterijski embolijski i trombotski događaji(uključujući prolaznu ishemijsku ataku, infarkt miokarda, cerebrovaskularni incident i okluziju mrežnične arterije) vidjeti dio 4.8.
In clinical studies with axitinib, arterial embolic and thrombotic events(including transient ischemic attack, myocardial infarction, cerebrovascular accident and retinal artery occlusion) were reported see section 4.8.

U ispitivanjima aksitiniba u monoterapiji(N 850) arterijski embolijski i trombotski događaji(uključujući prolaznu ishemijsku ataku, infarkt miokarda i cerebrovaskularni incident) prijavljeni su u 5,3% bolesnika koji su primali aksitinib.
In monotherapy studies with axitinib(N 850), arterial embolic and thrombotic adverse reactions(including transient ischemic attack, myocardial infarction, and cerebrovascular accident) were reported in 5.3% of patients receiving axitinib.

U kontroliranom kliničkom ispitivanju aksitiniba u terapiji bolesnika s RCC-om venski embolijski i trombotski događaji prijavljeni su u 3,9% bolesnika koji su primali aksitinib, uključujući plućnu emboliju(2,2%), okluziju/trombozu mrežnične vene(0,6%) i duboku vensku trombozu 0, 6.
In a controlled clinical study with axitinib for the treatment of patients with RCC, venous embolic and thrombotic adverse reactions were reported in 3.9% of patients receiving axitinib, including pulmonary embolism(2.2%), retinal vein occlusion/thrombosis(0.6%) and deep vein thrombosis 0.6.

Embolijska blokada ima iznenadan početak, stoga su simptomi obično najizraženiji već na početku.
Because the embolic blockage is sudden in onset, symptoms usually are maximal at the start.

Tromb kao takav(čak i ako je ne-okludirajući) može dovesti do embolijskog moždanog udara(vidi kasnije) ako se tromb otkine, te se tada naziva embolusom.
A thrombus itself(even if it does not completely block the blood vessel) can lead to an embolic stroke(see below) if the thrombus breaks off and travels in the bloodstream, at which point it is called an embolus.

U kontroliranom kliničkom ispitivanju aksitiniba u terapiji bolesnika s RCC-om, arterijske embolijske i trombotske nuspojave prijavljene su u 4,7% bolesnika koji su primali aksitinib, uključujući infarkt miokarda(1,4%), prolaznu ishemijsku ataku(0,8%) i cerebrovaskularni incident 0, 6.
In a controlled clinical study with axitinib for the treatment of patients with RCC, arterial embolic and thrombotic adverse reactions were reported in 4.7% of patients receiving axitinib, including myocardial infarction(1.4%), transient ischemic attack(0.8%) and cerebrovascular accident 0.6.

Pošto je blokada arterije postupna, početak simptoma je sporiji. Tromb kao takav(čak i ako je ne-okludirajući) može dovesti do embolijskog moždanog udara(vidi kasnije) ako se tromb otkine, te se tada naziva embolusom.
A thrombus itself(even if it does not completely block the blood vessel) can lead to an embolic stroke(see below) if the thrombus breaks off and travels in the bloodstream, at which point it is called an embolus.

Ukupno je bio 7001 bolesnik s moždanim udarom(53,6% s moždanom trombozom, 17,35% s moždanim udarom embolijske etiologije, 21,96% s moždanim krvarenjem i 1,17% sa subarahnoidnim krvarenjem).
There were 7001 stroke patients(53.6% with cerebral thrombosis, 17.35% with embolic etiology, 21.96% with intracerebral hemorrhage, and 1.17% with subarachnoid hemorrhage), with a 3.38% incidence of symptomatic epileptic seizures.